AbCellera Biologics Inc. Report issue

For profit Phase 3
Founded: Vancouver Canada (2012)

Organization Overview

First Clinical Trial
2020
NCT04411628
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AbCellera Biologics Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

ly3819253 (6 trials)

ly3832479 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 2